Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders

MILWAUKEE, June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in its transaction with Ceapro.

Click here to learn how to join our investigation: https://www.ademilaw.com/case/aeterna-zentaris-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

In the transaction each outstanding Ceapro common share were exchanged for 0.09439 of an Aeterna common share.  In addition, Aeterna issued to its shareholders 0.47698 of a share purchase warrant for each Aeterna common share held. Following the closing of the transaction, the former shareholders of Ceapro now own 50% of Aeterna and the pre-transaction securityholders of Aeterna now own the remaining 50%, assuming the exercise of all warrants. The transaction may not have been in the best interest of the shareholders of Aeterna. Insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Aeterna's board of directors, and whether they fulfilled their fiduciary duties to all shareholders.

If you own Aeterna common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/aeterna-zentaris-inc.                       

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                                                                    
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

SOURCE Ademi LLP